Does Ozempic Help With Belly Fat?

Summary: Ozempic does not spot-reduce belly fat, but it causes overall weight loss with a preferential reduction in visceral adipose tissue, the deep abdominal fat that drives cardiovascular and metabolic risk.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

The short answer: yes, but not in the way "targets belly fat" infomercials promise. Ozempic does not spot-reduce. It causes overall weight loss, and within that loss, visceral adipose tissue (the dangerous fat packed around your liver, intestines, and pancreas) drops at a higher rate than the soft subcutaneous fat under your skin. In the STEP-1 body composition substudy, participants lost roughly twice the proportion of visceral fat as total body weight ^[2]. That is the biological reason waistbands loosen faster than scales sometimes suggest.

Below: what visceral and subcutaneous fat actually are, what the STEP-1 imaging showed, why insulin sensitivity drives the preferential visceral loss, the numbers you can realistically expect, and what Ozempic cannot do for your lower-belly pouch or loose skin.

Visceral fat versus subcutaneous fat, and why the distinction matters

Belly fat is two different tissues sitting in the same neighborhood.

A man with a 42-inch waist and a soft belly might have most of that volume as subcutaneous fat. The guy next to him at the same waist size with a harder, rounder midsection often carries more visceral fat. The second pattern is worse for your heart, your liver, and your blood sugar, even though both look like "belly fat" in the mirror ^[4].

That distinction matters because Ozempic does not care how it looks. It cares about metabolism. And the fat that responds first to semaglutide is the metabolically active visceral kind.

What STEP-1 actually measured

The STEP-1 trial randomized 1,961 adults with overweight or obesity (without diabetes) to once-weekly semaglutide 2.4 mg (the Wegovy dose) or placebo for 68 weeks. Mean weight loss in the semaglutide arm was 14.9 percent of baseline body weight, versus 2.4 percent on placebo ^[1].

Inside that trial, a body composition substudy used DXA scans to measure where the lost weight came from. The headline numbers from the substudy:

• Total fat mass dropped substantially, much more than lean mass.
• The ratio of total fat to lean mass improved meaningfully.
• Visceral fat dropped disproportionately. Participants lost roughly 27 to 30 percent of their starting visceral adipose tissue while losing about 14 to 15 percent of total body weight ^[2].

So when you scale it: every 1 percent of body weight lost on semaglutide is associated with roughly 2 percent of visceral fat lost. That is a preferential mobilization, not random fat loss spread evenly across the body.

Why the visceral fat goes first

Three mechanisms drive the preferential visceral loss, and none of them are about Ozempic targeting your belly specifically.

Insulin sensitivity. Visceral fat is the most insulin-resistant tissue in the body. As semaglutide improves insulin sensitivity (a known effect, partly through weight loss and partly through direct GLP-1 receptor signaling), visceral adipocytes become more responsive to lipolysis signals. They release stored triglycerides more readily than subcutaneous fat does. The body burns what is easiest to mobilize first.

Lipolytic activity. Visceral fat has a higher density of beta-adrenergic receptors and a higher baseline lipolytic rate than subcutaneous fat. Under a sustained caloric deficit (which is what Ozempic creates by suppressing appetite), the metabolically active depot drains faster.

Portal circulation drainage. Visceral fat drains directly into the liver via the portal vein, which means the free fatty acids it releases hit the liver first. As that flux declines, hepatic fat (NAFLD) also declines, which improves insulin signaling further, which mobilizes more visceral fat. It is a self-reinforcing loop in the right direction.

The takeaway: Ozempic creates a caloric deficit through appetite suppression, and the body preferentially burns visceral fat because that fat is metabolically primed to be burned. The drug is not navigating to your stomach. Your stomach fat is just the easiest fat to get rid of once the deficit is sustained.

Realistic numbers for waist and belly changes

Forget the before-and-after photos for a second. Here is what the data supports.

These are STEP-1 averages on the 2.4 mg semaglutide dose used in Wegovy ^[1][2]. Ozempic is approved for type 2 diabetes at doses up to 2.0 mg, which produces somewhat less weight loss than Wegovy's 2.4 mg, but the directional pattern is identical. Visceral fat drops faster than total weight, and waist circumference shrinks faster than scale weight suggests.

Why this matters more than total weight loss

Cardiometabolic risk does not scale with body weight. It scales with visceral fat and ectopic fat (the lipid stored in your liver and pancreas) much more tightly. Two people at the same BMI can have wildly different cardiovascular risk profiles based on how much of their fat is visceral ^[4].

This is why the SELECT cardiovascular outcomes trial mattered. SELECT randomized 17,604 adults with overweight or obesity and established cardiovascular disease to semaglutide 2.4 mg or placebo. The semaglutide group had a 20 percent reduction in major adverse cardiovascular events (death from cardiovascular causes, non-fatal heart attack, non-fatal stroke) over a mean follow-up of 39.8 months ^[5]. The cardiovascular benefit was larger than what total weight loss alone would predict, which most researchers attribute to the disproportionate visceral fat reduction plus the direct anti-inflammatory and endothelial effects of GLP-1 receptor activation.

Put plainly: losing 15 pounds of visceral fat is worth more to your heart and liver than losing 15 pounds of generic body weight. Ozempic gives you the former.

What Ozempic does not fix: loose skin and the "lower belly" question

A common frustration appears around month 4 to 6: the upper belly tightens, the love handles shrink, but a soft lower pouch persists. Two things are usually happening.

Subcutaneous fat is slower. The lower abdominal subcutaneous depot, especially below the navel, is one of the slowest-mobilizing fat regions in the body. It responds, just not as fast as visceral fat or upper-abdominal fat. Continued caloric deficit plus time is the answer. Months 9 through 18 on semaglutide tend to flatten the lower abdomen if weight loss continues.

Skin elasticity is the other variable. If you have lost 40+ pounds, some of what remains around your midsection is skin and connective tissue that has lost the volume it was stretched around. That is not fat and Ozempic cannot do anything about it. Skin retraction takes 12 to 24 months after weight stabilizes, and in people with significant excess skin after large weight loss it often does not fully retract without surgical intervention.

Exercise that complements Ozempic (and what does not)

You cannot spot-reduce. A thousand crunches will not melt belly fat. The muscle under the fat gets stronger, but the fat layer above it responds to systemic caloric deficit, not to local muscle work. This has been demonstrated in dozens of controlled studies and has not changed.

What does help, layered on top of Ozempic.

Resistance training preserves lean mass. Roughly 25 to 40 percent of weight lost on semaglutide is lean tissue if you do nothing about it. Two to three resistance training sessions per week, focused on compound lifts (squats, deadlifts, presses, rows), drops that lean loss substantially. Less lean loss means a higher resting metabolic rate at goal weight, which means easier weight maintenance after you taper off the drug. See our muscle loss on semaglutide breakdown for the protein and lifting protocol.

Cardiovascular work increases visceral fat loss further. Aerobic exercise (150+ minutes per week of moderate intensity) independently reduces visceral fat above and beyond what diet-induced weight loss provides. Stacked with Ozempic, the visceral effect is additive.

Protein intake matters more than carb timing or fasted training. Aim for roughly 1.2 to 1.6 grams of protein per kilogram of body weight per day during active weight loss. That is the single biggest dietary lever for preserving muscle while semaglutide drives appetite down.

How long until the belly visibly changes?

On Ozempic 0.25 mg (the four-week starter dose) you will not see meaningful belly changes. That dose exists for tolerance, not results. By weeks 8 to 12, after titration to 1.0 mg or 2.0 mg, most people see waistband loosening and a clear midsection change. By six months, the visceral fat reduction is substantial and the cardiometabolic markers (fasting glucose, triglycerides, blood pressure, ALT for liver fat) typically improve in parallel.

If you are pairing Ozempic with resistance training and adequate protein, expect the visible midsection change to outpace the scale weight loss. That gap is the visceral fat going first, and it is the most clinically valuable part of the response.

Common questions about Ozempic and belly fat

Does Ozempic specifically target belly fat?

No drug spot-reduces. Ozempic causes overall weight loss with preferential visceral fat reduction, which makes the belly shrink faster proportionally than other areas.

How much weight can you lose on Ozempic?

At the 2.0 mg dose used for diabetes, roughly 10 to 12 percent of body weight over 12 months. At the 2.4 mg Wegovy dose, around 14.9 percent at 68 weeks per STEP-1.

What does Ozempic before and after 3 months look like?

Average total weight loss at 12 weeks is 5 to 8 percent, with visceral fat down 10 to 15 percent and waist circumference often down 1 to 2 inches.

What is the average weight loss per week on Ozempic?

After full titration, roughly 0.5 to 1.5 pounds per week is typical. Loss is faster in the first three months and slows as the body approaches a new setpoint.

How much Ozempic do I need to lose 20 pounds?

Most people on the 1.0 mg or 2.0 mg dose reach 20 pounds of loss between months 4 and 7, depending on starting weight, diet, and activity.

Why am I gaining weight on Ozempic?

Common causes include not yet being on a therapeutic dose, fluid retention in the first few weeks, calorie intake creeping back up, or muscle gain from resistance training masking fat loss on the scale.

Does Ozempic get rid of visceral fat?

Yes. The STEP-1 substudy showed visceral adipose tissue dropped roughly twice as fast proportionally as total body weight, and this drives most of the cardiovascular benefit.

Will my belly skin tighten after losing weight on Ozempic?

Skin retraction depends on age, elasticity, and how much weight was lost. Small to moderate losses usually retract within 12 to 24 months. Large losses may leave residual loose skin that does not fully retract without surgery.

Can I lose belly fat faster on Ozempic with cardio and crunches?

Cardio helps reduce visceral fat further. Crunches strengthen the muscle but do not burn the fat above it. Spot reduction is not real. Focus on systemic exercise, protein, and consistent dosing.

How does Ozempic compare to Wegovy for belly fat?

Same drug (semaglutide), different doses. Wegovy at 2.4 mg produces somewhat more weight loss and visceral fat reduction than Ozempic at 2.0 mg, but the pattern of preferential visceral loss is identical.

What this article does not cover

This page is about how Ozempic affects belly fat specifically. Total weight loss expectations, dosing schedules, side effect management, cost, and insurance coverage all have dedicated pages on this site. The visceral fat preference described here applies across the full semaglutide dose range, including Wegovy at 2.4 mg, but the magnitude of the effect tracks with the magnitude of total weight loss, which depends on dose, duration, and adherence.